GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Cyclically Adjusted Revenue per Share

Covalon Technologies (TSXV:COV) Cyclically Adjusted Revenue per Share : C$1.07 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Covalon Technologies's adjusted revenue per share for the three months ended in Dec. 2023 was C$0.189. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is C$1.07 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Covalon Technologies's average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Covalon Technologies was 20.30% per year. The lowest was 5.40% per year. And the median was 10.80% per year.

As of today (2024-05-24), Covalon Technologies's current stock price is C$1.10. Covalon Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was C$1.07. Covalon Technologies's Cyclically Adjusted PS Ratio of today is 1.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Covalon Technologies was 12.75. The lowest was 0.86. And the median was 2.36.


Covalon Technologies Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Covalon Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Cyclically Adjusted Revenue per Share Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.87 0.95 1.02 1.11

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.08 1.10 1.11 1.07

Competitive Comparison of Covalon Technologies's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Covalon Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Cyclically Adjusted PS Ratio falls into.



Covalon Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Covalon Technologies's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.189/125.0724*125.0724
=0.189

Current CPI (Dec. 2023) = 125.0724.

Covalon Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.110 98.604 0.140
201406 0.161 99.473 0.202
201409 0.128 99.394 0.161
201412 0.116 98.367 0.147
201503 0.247 99.789 0.310
201506 0.212 100.500 0.264
201509 0.225 100.421 0.280
201512 0.262 99.947 0.328
201603 0.075 101.054 0.093
201606 0.180 102.002 0.221
201609 0.046 101.765 0.057
201612 0.475 101.449 0.586
201703 0.254 102.634 0.310
201706 0.218 103.029 0.265
201709 0.612 103.345 0.741
201712 0.298 103.345 0.361
201803 0.239 105.004 0.285
201806 0.325 105.557 0.385
201809 0.239 105.636 0.283
201812 0.327 105.399 0.388
201903 0.600 106.979 0.701
201906 0.308 107.690 0.358
201909 0.283 107.611 0.329
201912 0.308 107.769 0.357
202003 0.204 107.927 0.236
202006 0.258 108.401 0.298
202009 -0.247 108.164 -0.286
202012 0.101 108.559 0.116
202103 0.166 110.298 0.188
202106 0.234 111.720 0.262
202109 0.256 112.905 0.284
202112 0.191 113.774 0.210
202203 0.127 117.646 0.135
202206 0.181 120.806 0.187
202209 0.212 120.648 0.220
202212 0.246 120.964 0.254
202303 0.290 122.702 0.296
202306 0.251 124.203 0.253
202309 0.287 125.230 0.287
202312 0.189 125.072 0.189

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Covalon Technologies  (TSXV:COV) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Covalon Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.10/1.07
=1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Covalon Technologies was 12.75. The lowest was 0.86. And the median was 2.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Covalon Technologies Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (TSXV:COV) Business Description

Industry
Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies (TSXV:COV) Headlines

No Headlines